Global 2-Way Foley Catheter Market Growth, Size, Trends Analysis - By Material, By Indication, By Usage, By End Use - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

2-Way Foley Catheter Market Introduction and Overview

According to SPER Market Research, the Global 2-Way Foley Catheter Market is estimated to reach USD 488.34 million by 2034 with a CAGR of 5.71%.

The report includes an in-depth analysis of the Global 2-Way Foley Catheter Market, including market size and trends, product mix, Applications, and supplier analysis. The 2-way foley catheter market is expected to grow at a compound annual growth rate (CAGR) of 5.71% from 2025 to 2034, from an estimated USD 280.26 million in 2024. The increasing incidence of urological conditions like bladder cancer and incontinence, as well as the growing demand for minimally invasive procedures, are the main causes of this growth. Furthermore, it is projected that improvements in healthcare infrastructure, especially in developing nations, will support the market's growth.

By Material Insights

The global market is divided into two categories based on material: silicone foley catheters and latex foley catheters. Due to its distinctive qualities that improve patient comfort and lower the risk of infection, the silicone segment held the largest market share in 2024. In order to reduce the risk of catheter-related urinary tract infections (CAUTIs), these catheters are infused with silver ions, which inhibit microbial growth. Because of their smoothness and flexibility, silicone Foley catheters are non-allergic and perfect for people with sensitive skin. They also make insertion less painful. They are also more tissue-friendly and usually have larger lumens for better drainage, which makes them a popular option for long-term use and helps the segment expand.

By Indication Insights

The global market is classified into three categories based on indication: urinary incontinence, enlarged prostate gland/BPH and spinal cord injury. Over the course of the forecast period, the spinal cord injury (SCI) segment is anticipated to grow at the fastest CAGR. Because damage to the nerves that transmit signals from the bladder to the brain impairs the ability to empty the bladder, spinal cord injuries can interfere with the regulation of bladder function.

By Usage Insights

Based on usage, the global market is separated into two segments: short term use and long-term use. In 2024, the market was dominated by the short-term use segment. Catheterization for less than 30 days is generally considered short-term use; however, in order to reduce the risk of complications and infections, the European Association of Urology Nurses (EAUN) recommends a maximum duration of no more than 14 days. Over the course of the forecast period, this segment is expected to grow at the fastest rate. The growing number of hospitals stays and surgical procedures requiring temporary urine drainage is driving the short-term use segment. The need for short-duration catheterization solutions is also being driven by post-operative care protocols and an increase in acute urinary retention cases in healthcare settings.

By End Use Insights

Based on end use type, the global market is separated into two segments: hospitals and long-term care facilities. In 2024, the hospital segment had the biggest share. The need for more extensive surgical intervention has been primarily caused by an increase in the prevalence of urological diseases. Because of their extensive treatment options and ability to handle any emergencies that may arise during surgeries, hospitals are especially preferred for urological procedures and other related therapies. Hospitals draw more patients than other healthcare facilities because they are better suited to manage complicated cases and offer specialized care.

By Regional Insights

In 2024, the North American 2-way foley catheter market held the largest global revenue share, primarily due to specific medical scenarios like treating complex urological conditions like bladder fistulas or reconstructive surgeries, managing severe haematuria with continuous bladder irrigation, and managing postpartum haemorrhage using uterine tamponade. The region's sophisticated healthcare system, greater surgical rates, and emphasis on all-encompassing urological and maternal care support this demand.

Market Competitive Landscape

The 2-way Foley catheter market is fiercely competitive, with global med-device majors and agile regional manufacturers competing on antimicrobial/coatings and material innovation, regulatory approvals, pricing, and distribution partnerships, while buyers prioritize infection prevention, safety, and cost. Some of the key market players are AdvaCare Pharma, Advin Health Care, ANGIPLAST PRIVATE LIMITED, B. Braun SE, Bactiguard AB, Cardinal Health, Coloplast Corp., HEMC (Hospital Equipment Manufacturing Company), Medtronic, Sterimed Group.

Recent Developments:

In May 2024, Coloplast has launched the Luja catheter for women in four markets, including the United States and Europe. This expansion came after the successful introduction of a men's version in several global regions, which addressed specific needs for female patients with urinary incontinence. The launch aimed to improve women's comfort and discretion while managing these conditions.

In January 2023, Bactiguard received the first MDR (Medical Device Regulation 2017/745) approval in Europe for the latex BIP 2-way Foley Catheter. This approval followed a rigorous authorization process and represents a significant milestone for the company. The BIP 2-way Foley Catheter incorporates Bactiguard's patented infection prevention technology, which uses a thin noble metal alloy coating to reduce microbial adhesion, lowering the risk of healthcare-associated infections (HAIs) and catheter-associated urinary tract infections.

Scope of the report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered By Material, By Indication, By Usage, By End Use

Regions covered North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered AdvaCare Pharma, Advin Health Care, ANGIPLAST PRIVATE LIMITED, B. Braun SE, Bactiguard AB, Cardinal Health, Coloplast Corp., HEMC (Hospital Equipment Manufacturing Company), Medtronic, Sterimed Group

Key Topics Covered in the Report

Global 2-Way Foley Catheter Market Size (FY'2021-FY'2034)

Overview of Global 2-Way Foley Catheter Market

Segmentation Global 2-Way Foley Catheter Market By Material (silicone foley catheters, latex foley catheters)

Segmentation Global 2-Way Foley Catheter Market By Indication (urinary incontinence, enlarged prostate gland/BPH, spinal cord injury)

Segmentation Global 2-Way Foley Catheter Market By Usage (short term use, long-term use)

Segmentation Global 2-Way Foley Catheter Market By End Use (hospitals, long-term care facilities)

Statistical Snap of Global 2-Way Foley Catheter Market

Expansion Analysis of Global 2-Way Foley Catheter Market

Problems and Obstacles in Global 2-Way Foley Catheter Market

Competitive Landscape in the Global 2-Way Foley Catheter Market

Details on Current Investment in Global 2-Way Foley Catheter Market

Competitive Analysis of Global 2-Way Foley Catheter Market

Prominent Players in the Global 2-Way Foley Catheter Market

SWOT Analysis of Global 2-Way Foley Catheter Market

Global 2-Way Foley Catheter Market Future Outlook and Projections (FY'2025-FY'2034)

Recommendations from Analyst